By integrating mechanistic and pharmacological insights, this work aims to establish a comprehensive theoretical framework for advancing SIRT1-based therapeutic strategies in MASLD
doi: 10.1016/j.parkreldis.2015.07.021 110 MehtaN.LuthraN
doi: 10.3389/fneur.2025.1663136 Received 10 July 2025 Accepted 18 August 2025 Published 02 September 2025 Volume 16 - 2025 Edited by Elvio Della Giustina, University Hospital of Modena, Italy Reviewed by Shayne Mason, North-West University, South Africa Valentina Magliocca, Bambino Ges Childrens Hospital, IRCCS, Italy Updates Copyright 2025 Tao, Huo, Hao and Liang
DNA was diluted to 100 ng l 1 in 0.4 M NaOH and 10 mM EDTA (pH 8.0) and denatured by heating at 100 C for 10 min
Clinical assessment required Healthcare professionals should evaluate each case individually to ensure medication compatibility and patient safety
B Immunoblot assay of proteins in relation to cell cycle in BPH-1 and WPMY-1 after overexpression of GPX3